Phase 3 Reflux Clinical Trials
8 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)
GERD (Gastroesophageal Reflux Disease)
Cinclus Pharma Holding AB500 enrolled75 locationsNCT07037875
Recruiting
Phase 3
Domperidone in Treating Patients With Gastrointestinal Disorders
Nausea and VomitingGastroparesisDyspepsia+4 more
M.D. Anderson Cancer Center200 enrolled1 locationNCT01696734
Recruiting
Phase 3
Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery
Ureter CancerRenal CancerOther Specified Disorders of Kidney and Ureter+5 more
Hans Bahlmann220 enrolled3 locationsNCT06349668
Recruiting
Phase 3
A Clinical Trial of Anaprazole for Treating Reflux Esophagitis.
Reflux Esophagitis (RE)
Xuanzhu Biopharmaceutical Co., Ltd.500 enrolled1 locationNCT07010107
Recruiting
Phase 3
LINX vs Fundoplication
Gastro-oesophageal reflux disease
University of Oxford460 enrolled5 locationsNCT07093359
Recruiting
Phase 3
A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis
Reflux Esophagitis (RE)
Livzon Pharmaceutical Group Inc.356 enrolled1 locationNCT06850480
Not Yet Recruiting
Phase 3
The effect of intravenous sedation on the lower oesophageal sphincter: A comparison between dexmedetomidine and remifentanil in healthy adult volunteers.
Aspiration Risk during sedationReflux and sedation
Dr Islam Elhalawani16 enrolled1 locationACTRN12611000794909
Recruiting
Phase 3
A trial of position control therapy for treatment of infantile gastrooesophageal reflux.
infantile gastrooesophageal
reflux (GOR) disease
Children Women Youth Health Service200 enrolled1 locationACTRN12609000988257